Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher tous les synonymes
Sélectionnez vos espèces d'intérêt
The functional diversity of JAM-A resides to a large part in a C-terminal PDZ domain binding motif which directly interacts with nine different PDZ domain-containing proteins. (Review)
JAM-A was expressed in all gliomas included in this study. The JAM-A intensity increased with malignancy grade, while its prognostic value was limited.
JAM-A protein plays protective role in pathogenesis of age related diseases as Atherosclerosis, Apoplexy, thrombosis, Hypertension, Ophthalmological pathology.Short peptides Lys (Montrer LYZ Protéines)-Glu (Montrer DCTN1 Protéines), Lys (Montrer LYZ Protéines)-Glu (Montrer DCTN1 Protéines)-Asp (Montrer ASIP Protéines), and Ala-Glu (Montrer DCTN1 Protéines)-Asp (Montrer ASIP Protéines)-Gly could influence on F11R gene expression leading to recovery of JAM-A synthesis in cells.
Dysregulation of JAM-A via p63 (Montrer RPE65 Protéines)/GATA-3 (Montrer GATA3 Protéines) signaling pathway occurs in squamous cell carcinomas of the head and neck.
JAM family members differentially regulate CXCR4 (Montrer CXCR4 Protéines) function and CXCL12 (Montrer CXCL12 Protéines) secretion in the bone marrow niche.
Our observations suggest that increased expression of JAM-A promotes neoplasia of lung adenocarcinoma. In addition, an anti-JAM-A antibody efficiently reduced cell proliferation and provoked apoptosis, indicating the potential feasibility of JAM-A-inhibitory cancer therapy.
a new role for CD321 in endothelial cells
We have shown that tension on JAM-A activates RhoA (Montrer RHOA Protéines) to control cell stiffness. Phosphorylation of JAM-A at S284 is required for activation of RhoA (Montrer RHOA Protéines) and increased cell stiffness in response to tension on the protein
Using patient-derived glioblastoma cancer stem cells, we confirmed that JAM-A is suppressed by miR (Montrer MLXIP Protéines)-145
Screening of a library of human cell surface membrane proteins showed that the Hom-1 vesivirus could utilize human junctional adhesion molecule 1 as a receptor to enter cells and initiate replication.
Deletion JAM-A from platelets increases early-stage neointima formation after carotid artery wire injury in hyperlipidemic mice.
JAM-A is present in the prostate and seminal vesicles and in all three regions of the epididymis where it is secreted in epididymosomes in the luminal fluid and can be delivered to sperm.
Soluble JAM-A secreted from cardiac progenitor cells reduces infiltration of neutrophils after myocardial infarction and ameliorates tissue damage through prevention of excess inflammation.
JAM-A up-regulation can increase the proliferation, cytokine secretion and wound-homing ability of MSCs, thus accelerating the repair rate of full-thickness skin defects
Endothelial JAM-A but not hematopoietic JAM-A facilitates reovirus T1L (Montrer CERS6 Protéines) bloodstream entry and egress.
Deletion of JAM-A causes a gain-of-function in platelets, with lower activation thresholds and increased inflammatory activities. This leads to an increase of plaque formation, particularly in early stages of the disease.
The F11r gene is directly regulated by retinoic acid in the embryonic mesoderm.
Redistribution of JAM-A in endothelial cells after stimulation with pro-atherogenic oxidized lipoproteins results in increased transmigration of mononuclear cells.
JAM-A has a prominent role in regulating leukocyte infiltration after brain I/R injury and could be a new target in limiting post-ischemic inflammation.
JAM-A regulates epithelial permeability via association with ZO-2 (Montrer TJP2 Protéines), afadin, and PDZ-GEF1 (Montrer RAPGEF2 Protéines) to activate Rap2c (Montrer RAP2C Protéines) and control contraction of the apical cytoskeleton.
Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. The protein encoded by this immunoglobulin superfamily gene member is an important regulator of tight junction assembly in epithelia. In addition, the encoded protein can act as (1) a receptor for reovirus, (2) a ligand for the integrin LFA1, involved in leukocyte transmigration, and (3) a platelet receptor. Multiple 5' alternatively spliced variants, encoding the same protein, have been identified but their biological validity has not been established.
junctional adhesion molecule 1
, junctional adhesion molecule A
, platelet F11 receptor
, platelet adhesion molecule 1
, BV11 antigen
, F11 receptor/F11R
, junction cell adhesion molecule A
, junction cell adhesion molecule1